This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liu, K. Articles by Roden, D. M. Search for Related Content PubMed PubMed Citation Articles by Liu, K. Articles by Roden, D. M. Related Collections Arrythmias-basic studies

(Circulation. 2005;112:3239-3246.)
© 2005 American Heart Association, Inc.

Arrhythmia/Electrophysiology

New Mechanism Contributing to Drug-Induced Arrhythmia

Rescue of a Misprocessed LQT3 Mutant

Kai Liu, MD; Tao Yang, PhD; Prakash C. Viswanathan, PhD; Dan M. Roden, MD

From the Departments of Medicine, Pharmacology, and Anesthesiology, Vanderbilt University School of Medicine, Nashville, Tenn.

Correspondence to Dan M. Roden, MD, Professor of Medicine and Pharmacology Director, Oates Institute for Experimental Therapeutics, Vanderbilt University School of Medicine, 1285B Medical Research Building IV, Nashville, TN 37232. E-mail dan.roden{at}vanderbilt.edu

Received May 22, 2005; revision received August 18, 2005; accepted September 1, 2005.

Background— The cardiac sodium channel (SCN5A) mutation L1825P has been identified in a patient with drug-induced torsade de pointes precipitated by the I_Kr blocker cisapride. Although L1825P generates late sodium current typical of SCN5A-linked long-QT syndrome (LQT3) in vitro, the patient reported had a normal QT interval before administration of the drug. To address this discrepancy, we tested the hypothesis that this mutant channel is not processed normally.

Methods and Results— CHO cells transfected with L1825P displayed significantly reduced peak I_Na (209±36 versus 23±3 pA/pF, P<0.05). Confocal imaging and cell-counting studies using epitope-tagged constructs demonstrated that cell surface expression of the mutant was only 9% of wild-type. Incubating transfected cells with cisapride partially rescued misprocessing to 30% of wild-type. As a result, "late" sodium current increased with cisapride from 1.2±0.11 to 5.04±0.77 pA/pF (P<0.05).

Conclusions— L1825P fails to generate QT prolongation because it does not reach the cell surface. Moreover, the data suggest that cisapride caused torsade de pointes not only by blocking I_Kr but also by rescuing cell surface expression of the mutant channel, further exaggerating the LQT3 phenotype. This not only represents a new mechanism in the drug-induced long-QT syndrome but also strongly supports the concept that variable cell surface expression contributes to clinical variability in the LQT3 phenotype.

---

 

CLINICAL PERSPECTIVE

This article has been cited by other articles:

				H. Itoh, T. Sakaguchi, W.-G. Ding, E. Watanabe, I. Watanabe, Y. Nishio, T. Makiyama, S. Ohno, M. Akao, Y. Higashi, et al. Latent Genetic Backgrounds and Molecular Pathogenesis in Drug-Induced Long-QT Syndrome Circ Arrhythm Electrophysiol, October 1, 2009; 2(5): 511 - 523. [Abstract] [Full Text] [PDF]

				C. A. Remme and A. A.M. Wilde SCN5A overlap syndromes: no end to disease complexity? Europace, November 1, 2008; 10(11): 1253 - 1255. [Full Text] [PDF]

				D. Darbar, P. J. Kannankeril, B. S. Donahue, G. Kucera, T. Stubblefield, J. L. Haines, A. L. George Jr, and D. M. Roden Cardiac Sodium Channel (SCN5A) Variants Associated with Atrial Fibrillation Circulation, April 15, 2008; 117(15): 1927 - 1935. [Abstract] [Full Text] [PDF]

				T. P. Nguyen, D. W. Wang, T. H. Rhodes, and A. L. George Jr Divergent Biophysical Defects Caused by Mutant Sodium Channels in Dilated Cardiomyopathy With Arrhythmia Circ. Res., February 15, 2008; 102(3): 364 - 371. [Abstract] [Full Text] [PDF]

				J. S. Lowe, O. Palygin, N. Bhasin, T. J. Hund, P. A. Boyden, E. Shibata, M. E. Anderson, and P. J. Mohler Voltage-gated Nav channel targeting in the heart requires an ankyrin-G dependent cellular pathway J. Cell Biol., January 10, 2008; 180(1): 173 - 186. [Abstract] [Full Text] [PDF]

				B.-H. Tan, P. Iturralde-Torres, A. Medeiros-Domingo, S. Nava, D. J. Tester, C. R. Valdivia, T. Tusie-Luna, M. J. Ackerman, and J. C. Makielski A novel C-terminal truncation SCN5A mutation from a patient with sick sinus syndrome, conduction disorder and ventricular tachycardia Cardiovasc Res, December 1, 2007; 76(3): 409 - 417. [Abstract] [Full Text] [PDF]

				S. E. Lehnart, M. J. Ackerman, D. W. Benson Jr, R. Brugada, C. E. Clancy, J. K. Donahue, A. L. George Jr, A. O. Grant, S. C. Groft, C. T. January, et al. Inherited Arrhythmias: A National Heart, Lung, and Blood Institute and Office of Rare Diseases Workshop Consensus Report About the Diagnosis, Phenotyping, Molecular Mechanisms, and Therapeutic Approaches for Primary Cardiomyopathies of Gene Mutations Affecting Ion Channel Function Circulation, November 13, 2007; 116(20): 2325 - 2345. [Abstract] [Full Text] [PDF]